Retaglutide and tirzepatide are innovative GLP-1 receptor agonists gaining attention as effective treatment options for type 2 diabetes. These medications stimulate insulin secretion from the pancreas, inhibit glucagon https://amaanybzd628527.pointblog.net/glp-1-receptor-agonists-retaglutide-and-tirzepatide-88426680